Camber Capital Management as of June 30, 2025
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 25 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 29.0 | $309M | 500k | 617.85 | |
| Zimmer Holdings (ZBH) | 8.6 | $91M | 1.0M | 91.21 | |
| Baxter International (BAX) | 8.1 | $86M | 2.9M | 30.28 | |
| Humana (HUM) | 6.9 | $73M | 300k | 244.48 | |
| CVS Caremark Corporation (CVS) | 6.8 | $72M | 1.1M | 68.98 | |
| Globus Med Cl A (GMED) | 4.4 | $47M | 800k | 59.02 | |
| Icon SHS (ICLR) | 4.1 | $44M | 300k | 145.45 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 4.1 | $43M | 250k | 172.60 | |
| Merck & Co (MRK) | 3.7 | $40M | 500k | 79.16 | |
| GSK Sponsored Adr Call Option (GSK) | 3.6 | $38M | 1.0M | 38.40 | |
| Pfizer (PFE) | 3.4 | $36M | 1.5M | 24.24 | |
| BioMarin Pharmaceutical (BMRN) | 3.1 | $33M | 600k | 54.97 | |
| UnitedHealth (UNH) | 2.9 | $31M | 100k | 311.97 | |
| Viatris (VTRS) | 2.3 | $25M | 2.8M | 8.93 | |
| Brookdale Senior Living (BKD) | 1.4 | $15M | 2.2M | 6.96 | |
| Zimvie (ZIMV) | 1.4 | $15M | 1.6M | 9.35 | |
| Apellis Pharmaceuticals (APLS) | 1.4 | $15M | 850k | 17.31 | |
| Myriad Genetics (MYGN) | 1.0 | $11M | 2.0M | 5.31 | |
| Evolent Health Cl A (EVH) | 0.9 | $9.6M | 850k | 11.26 | |
| Concentra Group Holdings Par Common Stock (CON) | 0.8 | $8.2M | 400k | 20.57 | |
| Inogen (INGN) | 0.6 | $6.9M | 975k | 7.03 | |
| Denali Therapeutics (DNLI) | 0.5 | $5.6M | 400k | 13.99 | |
| Theravance Biopharma (TBPH) | 0.5 | $5.0M | 450k | 11.03 | |
| Anaptysbio Inc Common (ANAB) | 0.3 | $2.8M | 125k | 22.20 | |
| OraSure Technologies (OSUR) | 0.3 | $2.7M | 900k | 3.00 |
